Occident
VC / Family office
1993
-
München, Bavaria, Germany
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Occident is a venture capital investor based in Munich, Germany, and Zug, Switzerland, founded in 2012. The firm is owner-managed and invests its own wealth, focusing on deep-tech startups, particularly those originating from scientific research. Occident's team consists of 7 professionals who are dedicated to supporting startups from the seed stage onwards, with a strong emphasis on sustainable and impactful investments.
Occident invests primarily in the life sciences and industrial tech sectors, with a focus on spin-offs from scientific research. The firm typically participates in seed and Series A rounds, with investments spread across Germany and Switzerland. Occident's portfolio includes companies such as Hemotune, Tubulis, and Lymphatica Medtech. The firm is known for its long-term commitment to its portfolio companies, providing both financial support and strategic guidance.
Notable investments by Occident include Hemotune - therapeutic devices, Tubulis - drug discovery, and Lymphatica Medtech - therapeutic devices. Occident has also participated in significant funding rounds, such as the €300 million Series C round for Tubulis, co-led by Venrock Healthcare Capital Partners.
